The trademark application VIVA SEPS CARE was filed by Viva in Vitro Diagnostics S.L., a corporation established under the laws of the Kingdom of Spain (the "Applicant"). The application was published for oppositions on July 12, 2023, and it was registered by office on October 19, 2023 without any oppositions.
The application was filed in Spanish (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Diagnostic preparations and materials
Diagnostic preparations for medical purposes
Reactants for medical diagnosis
Clinical diagnostic reagents
Veterinary diagnostic reagents
Diagnostic agents for pharmaceutical use
Diagnostic agents for medical use
Medical diagnostic reagents and assays for testing of body fluids
Reagents for use in diagnostic tests [for medical purposes]
Reagents and media for medical and veterinary diagnostic purposes
Diagnostic testing materials for medical use
Clinical medical reagents
Reagents for analytical purposes [for medical purposes]
Reagents for analytical purposes [for veterinary purposes].
The mark was filed in class 10 with following description of goods:
Medical and veterinary apparatus and instruments
Diagnostic, examination, and monitoring equipment
Tools for medical diagnostics
Diagnostic apparatus for medical purposes
Testing instruments for medical diagnostic purposes
Trace material analyzers for medical use in diagnosis
Testing apparatus for medical purposes
Medical analytical apparatus for medical purposes
Apparatus for carrying-out diagnostic tests for medical purposes
Detecting instruments for medical use
Detecting instruments for veterinary use.
The mark was filed in class 42 with following description of goods:
Medical and pharmacological research services
Design and development of medical diagnostic apparatus
Design and development of testing and analysis methods
Clinical research
Clinical trials
Providing medical and scientific research information in the field of pharmaceuticals and clinical trials.